BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 16859500)

  • 21. A prognostic gene expression profile that predicts circulating tumor cell presence in breast cancer patients.
    Molloy TJ; Roepman P; Naume B; van't Veer LJ
    PLoS One; 2012; 7(2):e32426. PubMed ID: 22384245
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression patterns as marker for 5-year postoperative prognosis of primary breast cancers.
    Onda M; Emi M; Nagai H; Nagahata T; Tsumagari K; Fujimoto T; Akiyama F; Sakamoto G; Makita M; Kasumi F; Miki Y; Tanaka T; Tsunoda T; Nakamura Y
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):537-45. PubMed ID: 15235906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic biomarkers related to breast cancer recurrence identified based on Logit model analysis.
    Zhou X; Xiao C; Han T; Qiu S; Wang M; Chu J; Sun W; Li L; Lin L
    World J Surg Oncol; 2020 Sep; 18(1):254. PubMed ID: 32977823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Using logistic regression to improve the prognostic value of microarray gene expression data sets: application to early-stage squamous cell carcinoma of the lung and triple negative breast carcinoma.
    Mount DW; Putnam CW; Centouri SM; Manziello AM; Pandey R; Garland LL; Martinez JD
    BMC Med Genomics; 2014 Jun; 7():33. PubMed ID: 24916928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
    Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
    Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
    Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J
    Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integration of RNA-Seq data with heterogeneous microarray data for breast cancer profiling.
    Castillo D; Gálvez JM; Herrera LJ; Román BS; Rojas F; Rojas I
    BMC Bioinformatics; 2017 Nov; 18(1):506. PubMed ID: 29157215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and development of an independent immune-related genes prognostic model for breast cancer.
    Chen L; Dong Y; Pan Y; Zhang Y; Liu P; Wang J; Chen C; Lu J; Yu Y; Deng R
    BMC Cancer; 2021 Mar; 21(1):329. PubMed ID: 33785008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognostic value of temporal in vitro and in vivo derived hypoxia gene-expression signatures in breast cancer.
    Starmans MH; Chu KC; Haider S; Nguyen F; Seigneuric R; Magagnin MG; Koritzinsky M; Kasprzyk A; Boutros PC; Wouters BG; Lambin P
    Radiother Oncol; 2012 Mar; 102(3):436-43. PubMed ID: 22356756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prognostic molecular classification of breast cancers based on gene expression profiling].
    Feng YM; Li XQ; Sun BC; Gao XC; Gu L; Niu Y; Hao XS
    Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):900-6. PubMed ID: 17533740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiogenomic analysis of breast cancer using MRI: a preliminary study to define the landscape.
    Yamamoto S; Maki DD; Korn RL; Kuo MD
    AJR Am J Roentgenol; 2012 Sep; 199(3):654-63. PubMed ID: 22915408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression.
    Morais-Rodrigues F; Silv Erio-Machado R; Kato RB; Rodrigues DLN; Valdez-Baez J; Fonseca V; San EJ; Gomes LGR; Dos Santos RG; Vinicius Canário Viana M; da Cruz Ferraz Dutra J; Teixeira Dornelles Parise M; Parise D; Campos FF; de Souza SJ; Ortega JM; Barh D; Ghosh P; Azevedo VAC; Dos Santos MA
    Gene; 2020 Feb; 726():144168. PubMed ID: 31759986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detecting prognostic biomarkers of breast cancer by regularized Cox proportional hazards models.
    Li L; Liu ZP
    J Transl Med; 2021 Dec; 19(1):514. PubMed ID: 34930307
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new statistical method for curve group analysis of longitudinal gene expression data illustrated for breast cancer in the NOWAC postgenome cohort as a proof of principle.
    Lund E; Holden L; Bøvelstad H; Plancade S; Mode N; Günther CC; Nuel G; Thalabard JC; Holden M
    BMC Med Res Methodol; 2016 Mar; 16():28. PubMed ID: 26944545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved breast cancer prognosis through the combination of clinical and genetic markers.
    Sun Y; Goodison S; Li J; Liu L; Farmerie W
    Bioinformatics; 2007 Jan; 23(1):30-7. PubMed ID: 17130137
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening of the prognostic targets for breast cancer based co-expression modules analysis.
    Liu H; Ye H
    Mol Med Rep; 2017 Oct; 16(4):4038-4044. PubMed ID: 28731166
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses.
    Abd El-Rehim DM; Ball G; Pinder SE; Rakha E; Paish C; Robertson JF; Macmillan D; Blamey RW; Ellis IO
    Int J Cancer; 2005 Sep; 116(3):340-50. PubMed ID: 15818618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The rapamycin-regulated gene expression signature determines prognosis for breast cancer.
    Akcakanat A; Zhang L; Tsavachidis S; Meric-Bernstam F
    Mol Cancer; 2009 Sep; 8():75. PubMed ID: 19778445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. From description to causality: mechanisms of gene expression signatures in cancer.
    Adler AS; Chang HY
    Cell Cycle; 2006 Jun; 5(11):1148-51. PubMed ID: 16721055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
    Bernhardt S; Bayerlová M; Vetter M; Wachter A; Mitra D; Hanf V; Lantzsch T; Uleer C; Peschel S; John J; Buchmann J; Weigert E; Bürrig KF; Thomssen C; Korf U; Beissbarth T; Wiemann S; Kantelhardt EJ
    Breast Cancer Res; 2017 Oct; 19(1):112. PubMed ID: 29020998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.